| pubmed-article:11165408 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11165408 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:11165408 | lifeskim:mentions | umls-concept:C0001792 | lld:lifeskim |
| pubmed-article:11165408 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:11165408 | lifeskim:mentions | umls-concept:C0337810 | lld:lifeskim |
| pubmed-article:11165408 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
| pubmed-article:11165408 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:11165408 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:11165408 | lifeskim:mentions | umls-concept:C0600688 | lld:lifeskim |
| pubmed-article:11165408 | lifeskim:mentions | umls-concept:C1511726 | lld:lifeskim |
| pubmed-article:11165408 | lifeskim:mentions | umls-concept:C0078257 | lld:lifeskim |
| pubmed-article:11165408 | lifeskim:mentions | umls-concept:C0045093 | lld:lifeskim |
| pubmed-article:11165408 | lifeskim:mentions | umls-concept:C0205390 | lld:lifeskim |
| pubmed-article:11165408 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:11165408 | lifeskim:mentions | umls-concept:C0331865 | lld:lifeskim |
| pubmed-article:11165408 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:11165408 | pubmed:issue | 2-3 | lld:pubmed |
| pubmed-article:11165408 | pubmed:dateCreated | 2001-2-22 | lld:pubmed |
| pubmed-article:11165408 | pubmed:abstractText | Following the demonstration that vinorelbine improves survival and quality of life compared with best supportive care in elderly patients with advanced non-small-cell lung cancer (NSCLC), we started the three-arm prospective Multicenter Italian Lung Cancer in the Elderly Study (MILES) trial of vinorelbine, gemcitabine and gemcitabine + vinorelbine. | lld:pubmed |
| pubmed-article:11165408 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11165408 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11165408 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11165408 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11165408 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11165408 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11165408 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11165408 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11165408 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11165408 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11165408 | pubmed:issn | 0169-5002 | lld:pubmed |
| pubmed-article:11165408 | pubmed:author | pubmed-author:GaspariniGG | lld:pubmed |
| pubmed-article:11165408 | pubmed:author | pubmed-author:FrontiniLL | lld:pubmed |
| pubmed-article:11165408 | pubmed:author | pubmed-author:AdamsRR | lld:pubmed |
| pubmed-article:11165408 | pubmed:author | pubmed-author:GalloCC | lld:pubmed |
| pubmed-article:11165408 | pubmed:author | pubmed-author:PerroneFF | lld:pubmed |
| pubmed-article:11165408 | pubmed:author | pubmed-author:GridelliCC | lld:pubmed |
| pubmed-article:11165408 | pubmed:author | pubmed-author:ManzioneLL | lld:pubmed |
| pubmed-article:11165408 | pubmed:author | pubmed-author:FerrelWW | lld:pubmed |
| pubmed-article:11165408 | pubmed:author | pubmed-author:CigolariSS | lld:pubmed |
| pubmed-article:11165408 | pubmed:author | pubmed-author:IannielloG... | lld:pubmed |
| pubmed-article:11165408 | pubmed:author | pubmed-author:NovelloSS | lld:pubmed |
| pubmed-article:11165408 | pubmed:author | pubmed-author:RobbiatiS FSF | lld:pubmed |
| pubmed-article:11165408 | pubmed:author | pubmed-author:MILES... | lld:pubmed |
| pubmed-article:11165408 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11165408 | pubmed:volume | 31 | lld:pubmed |
| pubmed-article:11165408 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11165408 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11165408 | pubmed:pagination | 277-84 | lld:pubmed |
| pubmed-article:11165408 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:11165408 | pubmed:meshHeading | pubmed-meshheading:11165408... | lld:pubmed |
| pubmed-article:11165408 | pubmed:meshHeading | pubmed-meshheading:11165408... | lld:pubmed |
| pubmed-article:11165408 | pubmed:meshHeading | pubmed-meshheading:11165408... | lld:pubmed |
| pubmed-article:11165408 | pubmed:meshHeading | pubmed-meshheading:11165408... | lld:pubmed |
| pubmed-article:11165408 | pubmed:meshHeading | pubmed-meshheading:11165408... | lld:pubmed |
| pubmed-article:11165408 | pubmed:meshHeading | pubmed-meshheading:11165408... | lld:pubmed |
| pubmed-article:11165408 | pubmed:meshHeading | pubmed-meshheading:11165408... | lld:pubmed |
| pubmed-article:11165408 | pubmed:meshHeading | pubmed-meshheading:11165408... | lld:pubmed |
| pubmed-article:11165408 | pubmed:meshHeading | pubmed-meshheading:11165408... | lld:pubmed |
| pubmed-article:11165408 | pubmed:meshHeading | pubmed-meshheading:11165408... | lld:pubmed |
| pubmed-article:11165408 | pubmed:meshHeading | pubmed-meshheading:11165408... | lld:pubmed |
| pubmed-article:11165408 | pubmed:meshHeading | pubmed-meshheading:11165408... | lld:pubmed |
| pubmed-article:11165408 | pubmed:meshHeading | pubmed-meshheading:11165408... | lld:pubmed |
| pubmed-article:11165408 | pubmed:meshHeading | pubmed-meshheading:11165408... | lld:pubmed |
| pubmed-article:11165408 | pubmed:meshHeading | pubmed-meshheading:11165408... | lld:pubmed |
| pubmed-article:11165408 | pubmed:meshHeading | pubmed-meshheading:11165408... | lld:pubmed |
| pubmed-article:11165408 | pubmed:meshHeading | pubmed-meshheading:11165408... | lld:pubmed |
| pubmed-article:11165408 | pubmed:meshHeading | pubmed-meshheading:11165408... | lld:pubmed |
| pubmed-article:11165408 | pubmed:articleTitle | Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non-small-cell lung cancer elderly patients: Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial. | lld:pubmed |
| pubmed-article:11165408 | pubmed:affiliation | Divisione di Oncologioca Medica B, Istituto Nazionale per lo Studio e la Cura dei Tumori, via M. Semmola, 80131 Naples, Italy. cgridelli@sirio-oncology.it | lld:pubmed |
| pubmed-article:11165408 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11165408 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11165408 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:11165408 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:11165408 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11165408 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11165408 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11165408 | lld:pubmed |
